Alfaro, C <br/><br/>
[The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].  [electronic resource] 

 -  Anales del sistema sanitario de Navarra   
 - 77-96 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1137-6627 
<br/><br/><label>Standard No.: </label>10.4321/s1137-66272006000100007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antigens, CD--immunology<br/>Antigens, Differentiation--immunology<br/>Antineoplastic Agents--therapeutic use<br/>Autoimmunity<br/>Bone Marrow Transplantation--immunology<br/>CTLA-4 Antigen<br/>Cancer Vaccines--immunology<br/>Chronic Disease<br/>Clinical Trials as Topic<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Cytokines--immunology<br/>Humans<br/>Immunotherapy<br/>Mice<br/>Mice, Transgenic<br/>Neoplasms--immunology<br/>Neoplasms, Experimental--drug therapy<br/>Receptors, Nerve Growth Factor--immunology<br/>Receptors, Tumor Necrosis Factor--immunology<br/>Transplantation, Homologous<br/>Tumor Cells, Cultured<br/>Tumor Necrosis Factor Receptor Superfamily, Member 9<br/>Viral Vaccines--immunology<br/>Virus Diseases--immunology